Chunxia Du

847 total citations · 1 hit paper
21 papers, 421 citations indexed

About

Chunxia Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Chunxia Du has authored 21 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Chunxia Du's work include Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Lung Cancer Research Studies (4 papers). Chunxia Du is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Lung Cancer Research Studies (4 papers). Chunxia Du collaborates with scholars based in China and United States. Chunxia Du's co-authors include Jinwan Wang, Yongkun Sun, Shuting Li, Wei Niu, Chuan Li, Li Li, Yihebali Chi, Feng Du, Feng‐Qing Wang and Hao Yu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Chunxia Du

17 papers receiving 416 citations

Hit Papers

Safety, pharmacokinetics, and antitumor properties of anl... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
    2016 332 citations Yongkun Sun, Wei Niu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunxia Du China 7 280 206 96 68 50 21 421
Kyrillus S. Shohdy Egypt 12 197 0.7× 213 1.0× 88 0.9× 59 0.9× 26 0.5× 39 440
Gary W. Jean United States 7 239 0.9× 92 0.4× 78 0.8× 56 0.8× 35 0.7× 14 375
Rambha Pandey India 10 181 0.6× 160 0.8× 69 0.7× 71 1.0× 41 0.8× 50 397
Teresa Alonso Gordoa Spain 11 284 1.0× 180 0.9× 84 0.9× 94 1.4× 99 2.0× 40 400
Adithya Chennamadhavuni United States 7 344 1.2× 121 0.6× 85 0.9× 41 0.6× 34 0.7× 18 446
İlhan Hacıbekiroğlu Türkiye 9 148 0.5× 118 0.6× 60 0.6× 55 0.8× 23 0.5× 48 260
Shinichiro Shimamatsu Japan 12 352 1.3× 277 1.3× 175 1.8× 51 0.8× 29 0.6× 40 580
Yuancheng Gou China 12 141 0.5× 108 0.5× 130 1.4× 172 2.5× 28 0.6× 16 395
Gregory Pennock United States 8 384 1.4× 132 0.6× 113 1.2× 74 1.1× 26 0.5× 22 527
Tomohiro Sakamoto Japan 11 237 0.8× 257 1.2× 101 1.1× 50 0.7× 24 0.5× 47 461

Countries citing papers authored by Chunxia Du

Since Specialization
Citations

This map shows the geographic impact of Chunxia Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Du more than expected).

Fields of papers citing papers by Chunxia Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Du. The network helps show where Chunxia Du may publish in the future.

Co-authorship network of co-authors of Chunxia Du

This figure shows the co-authorship network connecting the top 25 collaborators of Chunxia Du. A scholar is included among the top collaborators of Chunxia Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunxia Du. Chunxia Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Ya, Chunxia Du, Xinqi Cheng, et al.. (2025). Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study. The Journal of Clinical Endocrinology & Metabolism. 110(12). 3342–3353. 1 indexed citations
3.
Zhang, Xiaoyu, Jian Dong, Chunxia Du, et al.. (2025). ADAM9 mediates Cisplatin resistance in gastric cancer cells through DNA damage response pathway. Medical Oncology. 42(4). 122–122. 1 indexed citations
4.
Liu, Feng, Jian Dong, Chunxia Du, et al.. (2025). SDCBP Orchestrated Gastric Cancer Aggression Through Epithelial‐ Mesenchymal Transition and Macrophages M2 Polarization. Molecular Carcinogenesis. 64(7). 1247–1263. 1 indexed citations
5.
6.
7.
Lin, Weihao, Qi Zhang, Yarui Ma, et al.. (2024). MGST1 facilitates novel KRASG12D inhibitor resistance in KRASG12D-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis. Molecular Medicine. 30(1). 199–199. 4 indexed citations
8.
Zhang, Xiaojie, et al.. (2024). Perioperative chemotherapy improves survival of patients with locally advanced diffuse gastric cancer. World Journal of Gastrointestinal Surgery. 16(9). 2878–2892.
9.
10.
Du, Chunxia, et al.. (2022). Congenital hepatic cyst: Eleven case reports. World Journal of Clinical Cases. 10(25). 9112–9120. 2 indexed citations
11.
Huang, Guanghua, et al.. (2022). Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment. Translational Cancer Research. 11(7). 1880–1888. 6 indexed citations
12.
Wang, Bingzhi, Chunxia Du, Yibin Xie, et al.. (2021). New substituted molecular classifications of advanced gastric adenocarcinoma: characteristics and probable treatment strategies. SHILAP Revista de lepidopterología. 2(1). 50–59. 2 indexed citations
13.
Song, Yan, Chunxia Du, Wen Zhang, et al.. (2016). A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma. Asia-Pacific Journal of Clinical Oncology. 12(2). 174–180. 10 indexed citations
14.
Sun, Yongkun, Wei Niu, Feng Du, et al.. (2016). Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. Journal of Hematology & Oncology. 9(1). 332 indexed citations breakdown →
15.
Sun, Yongkun, Wei Niu, Yihebali Chi, et al.. (2015). Safety, pharmacokinetic, and antitumor activity of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.. Journal of Clinical Oncology. 33(15_suppl). e13586–e13586. 3 indexed citations
16.
Du, Chunxia, Ruoxi Hong, Yuankai Shi, Xiaoduo Yu, & Jinwan Wang. (2013). Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients. Journal of Neuro-Oncology. 115(2). 285–291. 19 indexed citations
17.
Han, Xueyan, Chunxia Du, L. Wang, et al.. (2013). Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy. Anaerobe. 24. 82–84. 20 indexed citations
18.
Wang, Yan, Liang Zhao, Chunxia Du, et al.. (2013). Individualized treatment of NSCLC: From research to clinical practice. Neoplasma. 60(5). 538–545. 7 indexed citations
19.
Liu, Yi, Chunxia Du, & Honggang Zhang. (2013). [Analysis of the prognosis of 111 patients with gastric cancer or adenocarcinoma of the esophagogastric junction combined with pleural or abdominal effusion].. PubMed. 35(9). 693–7. 1 indexed citations
20.
Zhou, Aiping, et al.. (2009). Clinical study of sorafenib in the treatment of Chinese patients with metastatic renal cell carcinoma. Zhonghua miniao waike zazhi. 30(1). 10–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyrillus S. Shohdy Breakdown of academic impact, for papers by Gary W. Jean Breakdown of academic impact, for papers by Rambha Pandey Breakdown of academic impact, for papers by Teresa Alonso Gordoa Breakdown of academic impact, for papers by Adithya Chennamadhavuni Breakdown of academic impact, for papers by İlhan Hacıbekiroğlu Breakdown of academic impact, for papers by Shinichiro Shimamatsu Breakdown of academic impact, for papers by Yuancheng Gou Breakdown of academic impact, for papers by Gregory Pennock Breakdown of academic impact, for papers by Tomohiro Sakamoto
Rankless by CCL
2026